| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |